+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report 2026-2033- Product Image
Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report 2026-2033- Product Image
New

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • July 2026
  • Region: Global
  • Grand View Research
  • ID: 5415599
REQUEST CUSTOMIZATION
Description Jump to:
The global biopharmaceutical third-party logistics market size was valued at USD 152.0 billion in 2025 and is projected to grow from USD 161.4 billion in 2026 to USD 258.4 billion by 2033, at a CAGR of 6.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 41.7% in 2025. The biopharmaceutical third-party logistics (3PL) industry is experiencing robust growth, driven by the expanding commercialization of biologics and biosimilars, increasing demand for temperature-controlled and GDP-compliant logistics infrastructure, rising outsourcing of supply chain operations by pharmaceutical and biotechnology companies, growth in clinical trials and advanced therapies including cell and gene therapies, and continuous investments in digital supply chain technologies for end-to-end product visibility and regulatory compliance.

The increasing complexity of global biopharmaceutical distribution, combined with stringent handling requirements for temperature-sensitive products and growing cross-border pharmaceutical trade, is encouraging manufacturers to partner with specialized third-party logistics providers offering integrated transportation, warehousing, packaging, inventory management, and cold chain capabilities.

The rapid expansion of biologics, biosimilars, and advanced therapies remains one of the primary factors driving market growth. Unlike conventional pharmaceuticals, biologics require specialized transportation, temperature-controlled storage, validated packaging, and continuous monitoring throughout the supply chain to preserve product efficacy and regulatory compliance. The growing commercialization of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies has significantly increased the demand for specialized logistics providers with GDP-certified infrastructure and global distribution networks.

Furthermore, increasing outsourcing of pharmaceutical supply chain operations is another major driver supporting market expansion. Pharmaceutical and biotechnology companies are increasingly relying on specialized third-party logistics providers to optimize distribution efficiency, improve regulatory compliance, reduce operational costs, and enhance supply chain resilience across global markets. Managing highly regulated biopharmaceutical supply chains requires specialized expertise in cold chain management, customs clearance, serialization, inventory control, and last-mile delivery, making outsourcing a cost-effective and scalable solution. Strategic investments and acquisitions across the logistics industry further demonstrate this trend. For instance, in March 2025, DHL announced the acquisition of specialty pharmaceutical logistics provider CryoPDP to strengthen its capabilities in clinical trial logistics, biopharma distribution, and cell and gene therapy transportation, further expanding its integrated healthcare logistics portfolio and specialized cold chain network.

However, the market growth is constrained by the high capital investment required for temperature-controlled infrastructure, stringent global regulatory compliance requirements, and the operational complexity associated with transporting highly sensitive biopharmaceutical products across international markets. Nevertheless, increasing commercialization of advanced therapies, expanding biologics pipelines, growing adoption of digital supply chain technologies, and continued investments in GDP-compliant cold chain infrastructure are expected to create substantial long-term opportunities for biopharmaceutical third-party logistics providers. The market is expected to maintain steady growth as pharmaceutical manufacturers increasingly outsource complex logistics operations to specialized partners capable of delivering secure, compliant, and globally integrated supply chain solutions.

Global Biopharmaceutical Third-party Logistics Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global biopharmaceutical third-party logistics market report based on supply chain, service type, and region:

To learn more about this report, Download Free Sample Report

- Supply Chain Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Cold Chain Logistics
  • Non-cold Chain Logistics

Service Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Transportation
  • Air Freight
  • Sea Freight
  • Overland
  • Warehousing and Storage
  • Other Services

Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Supply Chain
1.2.2. Service Type
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biopharmaceutical Third-Party Logistics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological Advancements in Logistics
3.2.1.2. Growing Applications of Reverse Logistics in the Biopharmaceutical Industry
3.2.1.3. Rising Demand for Cold Chain Logistics
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance Issues While Outsourcing
3.2.2.2. Stringent Regulatory Framework
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
Chapter 4. Biopharmaceutical Third-Party Logistics Market: Supply Chain Estimates & Trend Analysis
4.1. Biopharmaceutical Third-Party Logistics Market, Supply Chain: Segment Dashboard
4.2. Biopharmaceutical Third-Party Logistics Market, Supply Chain: Movement Analysis
4.3. Biopharmaceutical Third-Party Logistics Market Estimates & Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
4.4. Cold Chain Logistics
4.4.1. Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
4.5. Non-cold Chain Logistics
4.5.1. Non-cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 5. Biopharmaceutical Third-Party Logistics Market: Service Type Estimates & Trend Analysis
5.1. Biopharmaceutical Third-Party Logistics Market, Service Type: Segment Dashboard
5.2. Biopharmaceutical Third-Party Logistics Market, Service Type: Movement Analysis
5.3. Biopharmaceutical Third-Party Logistics Market Estimates & Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
5.4. Transportation
5.4.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.2. Air Freight
5.4.2.1. Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.3. Sea Freight
5.4.3.1. Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.4.4. Overland
5.4.4.1. Overland Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.5. Warehousing and Storage
5.5.1. Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
5.6. Other Services
5.6.1. Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 6. Biopharmaceutical Third-Party Logistics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2025 & 2033
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5.5. Australia
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5.6. Thailand
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7.3. UAE
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7.4. Saudi Arabia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7.6. Qatar
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
6.7.7. Oman
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 7. Competitive Landscape
7.1. Key Participant Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
7.3. Company Profiles
7.3.1. DHL International GmbH
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. SF Express
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. FedEx
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. United Parcel Service of America, Inc.
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Cencora, Inc.
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. DB Schenker
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Kuehne and Nagel
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Kerry Logistics Network Limited
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Agility Public Warehousing Company K.S.C.P.
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Region, 2021 - 2033 (USD Million/Billion)
Table 4. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 5. Global Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 6. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million/Billion)
Table 7. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 8. North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 9. U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 10. U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 11. Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 12. Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 13. Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 14. Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 15. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million/Billion)
Table 16. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 17. Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 18. UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 19. UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 20. Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 21. Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 22. France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 23. France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 24. Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 25. Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 26. Spain Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 27. Spain Biopharmaceutical Third-Party LogisticsMarket Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 28. Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 29. Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 30. Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 31. Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 32. Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 33. Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 34. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million/Billion)
Table 35. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 36. Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 37. Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 38. Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 39. China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 40. China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 41. India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 42. India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 43. Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 44. Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 45. South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 46. South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 47. Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 48. Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 49. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million/Billion)
Table 50. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 51. Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 52. Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 53. Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 54. Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 55. Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 56. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million/Billion)
Table 57. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 58. Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 59. South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 60. South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 61. Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 62. Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 63. UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 64. UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 65. Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 66. Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 67. Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 68. Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
Table 69. Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Supply Chain, 2021 - 2033 (USD Million/Billion)
Table 70. Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, Service Type, 2021 - 2033 (USD Million/Billion)
List of Figures
Fig. 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2025 (USD Billion)
Figure 15 Ancillary market outlook, 2025 (USD Billion)
Figure 16 Biopharmaceutical Third-Party Logistics Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Biopharmaceutical Third-Party Logistics Market: Supply Chain outlook and key takeaways (USD Million/Billion)
Figure 20 Biopharmaceutical Third-Party Logistics Market: Supply Chain movement analysis
Figure 21 Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 22 Non-cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 23 Biopharmaceutical Third-Party Logistics Market: Service Type outlook and key takeaways (USD Million/Billion)
Figure 24 Biopharmaceutical Third-Party Logistics Market: Service Type movement analysis
Figure 25 Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 26 Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 27 Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 28 Overland Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 29 Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 30 Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 31 Regional Marketplace: Key Takeaways
Figure 32 North America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 33 U.S. Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 34 Canada Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 35 Mexico Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 36 Europe Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 37 UK Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 38 Germany Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 39 France Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 40 Italy Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 41 Spain Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 42 Sweden Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 43 Denmark Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 44 Norway Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 45 Asia Pacific Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 46 Japan Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 47 China Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 48 India Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 49 Thailand Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 50 South Korea Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 51 Australia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 52 Latin America Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 53 Brazil Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 54 Argentina Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 55 Middle East & Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 56 South Africa Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 57 Saudi Arabia Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 58 UAE Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 59 Kuwait Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 60 Oman Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Figure 61 Qatar Biopharmaceutical Third-Party Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)

Companies Mentioned

  • DHL International GmbH
  • SF Express
  • FedEx
  • United Parcel Service of America, Inc.
  • Cencora, Inc.
  • DB Schenker
  • Kuehne and Nagel
  • Kerry Logistics Network Limited
  • Agility Public Warehousing Company K.S.C.P.

Related Topics

Related Reports

Healthcare Third-party Logistics Market Size, Share & Trends Analysis Report by Industry, Supply Chain, Service, Region, and Segment Forecasts, 2026-2033 - Product Image

Healthcare Third-party Logistics Market Size, Share & Trends Analysis Report by Industry, Supply Chain, Service, Region, and Segment Forecasts, 2026-2033

  • Report
  • 180 Pages
  • Global
From
Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033 - Product Image

Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Biopharmaceutical Third-Party Logistics Market Report 2026 - Product Image

Biopharmaceutical Third-Party Logistics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Biopharmaceutical Third Party Logistics Market - Global Forecast 2026-2032 - Product Image

Biopharmaceutical Third Party Logistics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Biopharmaceutical Cold Chain Third Party Logistics Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Biopharmaceutical Cold Chain Third Party Logistics Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 93 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.